Collaborative Agreement Sample Contracts

Ocean Power Technologies, Inc. – Ocean Power Technologies and Acteon Field Life Services Announce Collaborative Agreement (April 5th, 2019)

MONROE TOWNSHIP, N.J., April 4, 2019 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NASDAQ: OPTT), a leader in innovative ocean energy solutions, and Acteon Field Life Services Ltd, a subsidiary of Acteon Group Ltd and a leading subsea services and solutions company, today announced a non-exclusive memorandum of understanding (“the Agreement”) to develop, explore and exploit mutual opportunities in the global oil and gas and renewable markets.

Cardiovascular Systems Inc – CARDIOVASCULAR SYSTEMS, INC. AND AEROLASE CORP. SIGN COLLABORATIVE AGREEMENT FOR LASER ATHERECTOMY TECHNOLOGY (July 31st, 2018)

Scott Ward, CSI’s Chairman, President and Chief Executive Officer, said, “We believe there is an opportunity to leverage Aerolase’s innovative proprietary laser technology, which is FDA-cleared for dermatology and medical aesthetic uses and supported by leading physicians in those fields. The collaboration project aims to create a significant improvement in the quality of care for patients suffering from peripheral arterial disease and in-stent restenosis.”

American BriVision (Holding) Corp – COLLABORATIVE AGREEMENT (July 24th, 2017)

BioFirst Corpation, a company incorporated under the laws of Taiwan and having its principal place of business at 3rd Floor, 248, Nei-Hu Road, Sec. 1, Taipei, 11493 Taiwan (“BioFirst”)

American BriVision (Holding) Corp – COLLABORATIVE AGREEMENT (November 15th, 2016)

BioLite Inc., a company incorporated under the laws of Taiwan and having its principal place of business at 3rd Floor, 248, Nei-Hu Road, Sec. 1, Taipei, 11493 Taiwan (“BioLite”)

Spherix Inc – Spherix Announces Collaborative Agreement To Monetize Patents Spherix Begins Program to Diversify Revenue Options (August 2nd, 2016)

BETHESDA, MD, March 8, 2016 /PRNewswire/ — Spherix Incorporated (Nasdaq: SPEX) — an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, today provided an update on the Company's monetization efforts and announced a collaboration agreement with Equitable IP Corporation (“Equitable”), a leading patent enforcement and monetization fund.

American BriVision (Holding) Corp – COLLABORATIVE AGREEMENT (June 9th, 2016)

BioLite Inc., a company incorporated under the laws of Taiwan and having its principal place of business at 3rd Floor, 248, Nei-Hu Road, Sec. 1, Taipei, 11493 Taiwan (“BioLite”)

China Media Group CORP – Launch of m-Commerce Services with Angkasa and Website Kuala Lumpur, Malaysia, April 20, 2016 - MEDIAN GROUP INC today announce it has signed an exclusive collaborative agreement with MYANGKASA HOLDINGS SDN BHD, a wholly-owned subsidiary of the Malaysian National Co-operative Organisation (ANGKASA) to launch a mobile commerce service under its Mobile Virtual Network Operator platform. MEDIAN, through its subsidiary NAIM INDAH MOBILE COMMUNICATIONS SDN BHD (“NIMC”), is en-route to becoming Asia’s next full-blown premiere digital service provider (DSP) MVNO through a collaborative partnership wi (April 21st, 2016)

Kuala Lumpur, Malaysia, April 20, 2016 - MEDIAN GROUP INC today announce it has signed an exclusive collaborative agreement with MYANGKASA HOLDINGS SDN BHD, a wholly-owned subsidiary of the Malaysian National Co-operative Organisation (ANGKASA) to launch a mobile commerce service under its Mobile Virtual Network Operator platform.

American BriVision (Holding) Corp – COLLABORATIVE AGREEMENT (February 16th, 2016)

BioLite Inc., a company incorporated under the laws of Taiwan and having its principal place of business at 3rd Floor, 248, Nei-Hu Road, Sec. 1, Taipei, 11493 Taiwan (“BioLite”)

Cryoport, Inc. – Cryoport Increases Revenue by 65% for the First Six Months of Fiscal 2015 Revenue growth driven by broader customer base, expanded distribution and increased customer utilization Now has collaborative agreements with the three major global carriers accounting for over 220 countries. (November 12th, 2014)

LAKE FOREST, CA – November 12, 2014 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for its second quarter and six months ended September 30, 2014.

Neurotrope, Inc. – Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C (July 22nd, 2014)

This development program is being conducted in partnership with Dr. Yiannis Ioannou, Professor of Genetics and Genomic Sciences at Mount Sinai. In addition, the Company has applied, on behalf of itself and Mount Sinai, for a provisional patent with the U.S. Patent and Trademark Office to protect their ability to use and commercialize bryostatin technology for this disease indication.

SunVault Energy, Inc. – March 12, 2014 09:30 ET Sunvault Energy Signs Collaborative Agreement With Massachusetts Institute of Technology (March 17th, 2014)

BELLINGHAM, WASHINGTON--(Marketwired - March 12, 2014) - SUNVAULT ENERGY INC. (OTCQB:SVLT) ("Sunvault") ("the Company") is pleased to announce that at a recent meeting and decision by its board of directors, the Company has signed a collaborative agreement to support Sunvault Energy's overall growth initiatives with the Massachusetts Institute of Technology (MIT).

Premier Biomedical Inc – COLLABORATIVE AGREEMENT (May 14th, 2012)

This Collaborative Agreement (the "Agreement") is made between The University of Texas at El Paso, ("University"), an institution of The University of Texas System ("System"), and Premier Biomedical, Inc., a corporation with its place of business at: 10805 Fallen Leaf Lane Port Richey, FL 34668 ("Company").

Biovest International Inc – Biovest and U.S. Army Enter into Collaborative Agreement to Develop Novel Bioreactor Systems as Platform Technology for Production of Anti-Viral Vaccines and Drugs (April 23rd, 2012)

TAMPA, FL and MINNEAPOLIS, MN – April 23, 2012 – Biovest International, Inc. (OTCQB: “BVTI”), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: “ABPI”), today announced that Biovest and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have entered into a Cooperative Research and Development Agreement (CRADA) to further develop Biovest’s hollow fiber perfusion bioreactors as a flexible and modular manufacturing platform for the rapid, robust and cost-effective production of medical countermeasures to emerging and genetically engineered infectious diseases. This CRADA utilizes Biovest’s hollow fiber technology for production of vaccines, virus-like particles (VLPs) and antibodies for treatment and prevention of filovirus diseases including those caused by Ebola and Marburg viruses.

Thorium Power, Ltd – INITIAL COLLABORATIVE AGREEMENT (July 23rd, 2009)

AREVA, a French public limited company with a management board and supervisory board organized and existing under the laws of France, with capital of 1,346,822,638 euros, registered under N° 712 054 923 at the Paris Registry of Trade and Commerce, and whose registered head-office address is 33, rue La Fayette, 75009 Paris Cedex, acting for itself and in the name of its Affiliates represented by Mr. Patrick CHAMPALAUNE in his capacity as Senior Vice President, Purchasing,

VIASPACE Inc. – COLLABORATIVE AGREEMENT between VIASPACE/ARROYO SCIENCES and RAYTHEON COMPANY (May 15th, 2007)

THIS TEAMING AGREEMENT is made and entered into between VIASPACE, a Nevada corporation existing under the laws of the State of California, acting solely by and through its Arroyo Sciences Subsidiary (hereinafter referred to as VIASPACE/Arroyo Sciences), and RAYTHEON COMPANY, a corporation organized and existing under the laws of the state of Delaware, acting solely by and through its Network Centric Systems business (hereinafter referred to as “Raytheon NCS”)

Senomyx Inc – Recent Accomplishments Include the Addition of a Seventh Market Leading Partner and an Expanded Collaborative Agreement (May 3rd, 2007)

SAN DIEGO, CA – May 3, 2007 – Senomyx, Inc. (NASDAQ: SNMX), a company focused on using proprietary taste receptor-based assays to discover novel flavor ingredients for the packaged food and beverage industry, today reported financial results for the first quarter ended March 31, 2007.  Revenues were $3.1 million for the first quarter of 2007, compared to $2.4 million for the first quarter of 2006, an increase of 27%.  The increase is primarily due to revenue recognition that commenced in the second quarter of 2006 in conjunction with a collaborative agreement.  As of March 31, 2007 the Company had cash, cash equivalents and short term investments of approximately $67.6 million.

Senomyx Inc – SOLAE, SENOMYX ENTER INTO COLLABORATIVE AGREEMENT FOR DISCOVERY, DEVELOPMENT, COMMERCIALIZATION OF SOY PROTEINS WITH ENHANCED FLAVOR (April 25th, 2007)

SAN DIEGO, CA and ST. LOUIS, MO – April 25, 2007 – Senomyx, Inc. (NASDAQ: SNMX), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the packaged food and beverage industry, and Solae, a joint venture with DuPont (NYSE: DD) and Bunge Limited (NYSE: BG) that is the leading supplier of soy protein for food-based products, announced today that they have entered into a collaborative agreement for the discovery, development and commercialization of novel flavor ingredients intended to enhance the taste characteristics of soy proteins.

Cdoor Corp – Collaborative Agreement for Development of Genetic Engineering Malaria Vaccine Party A: Shanghai Wanxing Bio-Pharmaceuticals Co. LTD Party B: Second Military Medical University, PLA (January 16th, 2007)

In order to accelerate the developing process of genetic engineering malaria vaccine and put it into the clinical use as soon as possible, based on the principles of equality, Mutual beneficial and good faith, Party A and Party B entered into a Cooperative Agreement for Development of Genetic Engineering Malaria Vaccine.

Detroit Edison Co – August 31, 2006 Overview A settlement agreement was announced today in Detroit Edison’s show cause proceeding (U-14838). Detroit Edison worked with the Michigan Public Service Commission Staff and other parties to develop this settlement, which has been submitted for review and approval by the Michigan Public Service Commission (MPSC). The company believes this collaborative agreement is indicative of the ongoing constructive regulatory environment in Michigan. The full settlement agreement is posted on the MPSC’s website: http://efile.mpsc.cis.state.mi.us/efile/electric.html (August 31st, 2006)

This settlement provides additional regulatory certainty through continued progress to reduce the level of rate skewing, the creation of a Choice Incentive Mechanism, the deferral and amortization of the costs to achieve savings from the Performance Excellence Process and a modest rate reduction. This settlement agreement does not alter DTE Energy’s consolidated 2006 operating earnings guidance excluding synfuels of $2.41-2.66 per diluted shareii. Furthermore, Detroit Edison remains positioned to earn its authorized 11% ROE in 2006 & 2007.

Vical Inc – Vical Announces News Release and Conference Call Schedule to Discuss Collaborative Agreement With AnGes MG for Allovectin-7(R) (May 30th, 2006)

SAN DIEGO, May 29 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced that the company will report terms of a collaborative agreement with AnGes MG, Inc. (TSE Mothers: 4563) for Vical’s Allovectin-7(R) cancer immunotherapeutic before the opening of trading on Tuesday, May 30, and conduct a conference call and webcast to discuss additional details of the agreement with invited analysts and institutional investors at 10 a.m. Eastern Time on Tuesday, May 30.  The call is open on a listen-only basis to any interested parties.  The call also will be available live and archived through the webcast center at www.vical.com.

Lumera Corp – Lumera Reports Third Quarter 2005 Results and Updates Product Development Progress BOTHELL, WA. (November 3, 2005) -- Lumera Corporation (NASDAQ: LMRA), an emerging leader in the field of nanotechnology, today reported financial results for the third quarter of 2005 and released information regarding its current product development progress. Revenues for the three months ended September 30, 2005 increased by $389,000 to $681,000 compared to $292,000 for the same period in 2004. For the nine months ended September 30, 2005, revenues increased by $373,000 to $1,269,000 compared to $896,000 for t (November 3rd, 2005)
Genomic Health Inc – AMENDMENT TO THE LIFESEQ COLLABORATIVE AGREEMENT (July 15th, 2005)

This Amendment to the LifeSeq Collaborative Agreement (the “LifeSeq Amendment”) effective as of December 21, 2001 (the “Amendment Effective Date”), is entered into by and between Incyte Genomics, Inc., a Delaware corporation, with a place of business at 3160 Porter Drive, Palo Alto, CA 94304 (“Incyte”) and Genomic Health, Inc., a Delaware corporation, with a place of business at 301 Penobscot Drive, Redwood City, CA 94063 (“GHI”).

Genomic Health Inc – *** Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. LIFESEQ COLLABORATIVE AGREEMENT between INCYTE GENOMICS, INC. And GENOMIC HEALTH, INC. (July 15th, 2005)

This Agreement is entered into as of this 30th day of March, 2001 (the “Effective Date”) by and between Genomic Health, Inc., a Delaware corporation (“GHI”), having its principal place of business at 101 University Ave., Suite 220, Palo Alto, CA 94301, and Incyte Genomics, Inc., a Delaware corporation (“Incyte”), having its principal place of business at 3160 Porter Drive, Palo Alto, CA 94304.

Genomic Health Inc – *** Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. Amendment #3 to LifeSeq® Collaborative Agreement (July 15th, 2005)

This Amendment to the LifeSeq® Collaborative Agreement (this “Amendment”) is entered into as of October 25,2004 (the “Amendment Effective Date”) by and between Incyte Corporation (f/k/a Incyte Genomics, Inc.), a Delaware Corporation (“Incyte”) and Genomic Health, Inc., a Delaware corporation (“GHI”).

Asia Broadband Inc – Collaborative Agreement (May 5th, 2004)

Party A was founded as a Sino-foreign joint equity enterprise on December 31, 1994 with approval of the State Industry and Commerce Administration of the People's Republic of China. Currently. Party A owns and operates a 5A-class intelligent office building, Shanghai Inforservice Tower. Through a signed agreement, Party A has been appointed by the information industry authority of Shanghai-Leading Group's Office of Shanghai National Economic and Social Information-as one of the four information hubs of Shanghai Information Port Broadband Network. Party A has obtained licenses for ICP and ISP issued by relevant government authorities.

Asia Broadband Inc – Collaborative Agreement (May 5th, 2004)

After extensive negotiations based on "Sino-Foreign Joint Venture Law", the three Partners have reached an agreement to establish Shanghai Broadband Network, Inc. as follows.

Asia Broadband Inc – Collaborative Agreement (May 5th, 2004)

To support part A's business of developing broadband network services in Shanghai area, part B is agreed to completely transfer the advanced benefits of using broadband network stated in the agreement signed together with The Information Leading Group Office Technology Center.

Asia Broadband Inc – Collaborative Agreement (May 5th, 2004)

Part A: Shanghai Information Plaza Enterprise Development Ltd. Part B: Information leading group office technology center Part C: Merendon International Inc.

Asia Broadband Inc – Collaborative Agreement on Developing Fudan Bilingual International Business Training Course Project Cooperative Parts: Part A: Fudan University Online Education College Part B: Shanghai Broadband Networks Inc. (May 5th, 2004)

Part A: Fudon Online Education College was established in 2000 which is one of the youngest institutes. Its goal is to cultivate high level qualified talent for this society. Based on its abundant teaching resources, advanced management and its teaching tenet - high starting point, high standard and high scale, Fudan is trying to be one of the most influential online education colleges with the 5 years.

Naturol Holdings Ltd – Collaborative Agreement (January 8th, 2004)

This collaborative agreement (the "Agreement") is entered into this eleventh day of December 2003, by and between Integrated Environmental Technologies Ltd. ("IET"), a Nevada corporation having its principal offices at 201 East Elizabeth Street, Elizabeth City, North Carolina 27709, and Coastal Carolina University (the "University"). Together, IET and the University are the "Parties."

Terayon Communication Systems – COMCAST ENTERS INTO COLLABORATIVE AGREEMENT WITH TERAYON FOR DEVELOPMENT OF DOCSIS 2.0 DATA HEADEND PLATFORM (October 7th, 2003)

PHILADELPHIA and SANTA CLARA, Calif. – Terayon Communication Systems, Inc. (Nasdaq: TERN) DOCSIS 2.0-qualified Cable Modem Termination System (CMTS) equipment will be used in the development of Comcast’s headend platforms as a way to expedite the ubiquitous adoption of DOCSIS 2.0 in Comcast’s networks, the companies announced today.

Zymogenetics Inc – Collaborative Agreement for IL-21 (March 28th, 2003)
Smartire Systems Inc – COLLABORATIVE AGREEMENT BETWEEN Visteon Corporation and SmarTire Systems, Inc (December 26th, 2002)
Corvas International Inc – COLLABORATIVE AGREEMENT (August 14th, 2001)
Diadexus Inc – COLLABORATIVE AGREEMENT (April 9th, 2001)